首页> 外国专利> NOVEL CHIMPANZEE ADENOVIRUS VECTOR, CONSTRUCTION METHOD THEREFOR, AND APPLICATION THEREOF

NOVEL CHIMPANZEE ADENOVIRUS VECTOR, CONSTRUCTION METHOD THEREFOR, AND APPLICATION THEREOF

机译:新型黑猩猩腺病毒载体,其施工方法及其应用

摘要

A novel chimpanzee adenovirus vector, a construction method therefor, and an application thereof. The chimpanzee adenovirus vector has higher virus titer, and a measurement method for the virus titer thereof is provided. An annular chimpanzee adenovirus vector is constructed by means of a shuttle plasmid, and E1 and E3 are knocked out by means of CRISPR/Cas9, thus a replication-deficient chimpanzee adenovirus vector is constructed. The chimpanzee adenovirus vector has no pre-existing antibody in people; E1 and E3 knockout is secure, and is significantly different from human adenovirus 5 type E1 in 293 cells; the chimpanzee adenovirus vector can greatly avoid recovery mutation (RCA) and is more secure. A constructed novel coronavirus vaccine is strong in vaccine stability after dozens of generations, does not cause mutation, and can induce strong humoral immunity and cellular response in a mouse model.
机译:一种新的黑猩猩腺病毒载体,其构造方法及其应用。 黑猩猩腺病毒载体具有较高的病毒滴度,提供了一种用于病毒滴度的测量方法。 环形黑猩猩腺病毒载体通过梭子质粒构建,通过CRISPR / CAS9敲除E1和E3,因此构建了一种复制缺陷的黑猩猩腺病毒载体。 Chimpanzee腺病毒载体在人们中没有预先存在的抗体; E1和E3敲除是安全的,与293个细胞中的人腺病毒5型E1显着不同; 黑猩猩腺病毒矢量可以大大避免恢复突变(RCA),更安全。 构建的新型冠状病毒疫苗在数十代之后疫苗稳定性较强,不会引起突变,并且可以在小鼠模型中引起强烈的体液免疫和细胞反应。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号